1. High expression of VEGF and PI3K in glioma stem cells provides new criteria for the grading of gliomas
   LEI WANG et al, 2016 CrossRef
2. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
   Bojin Zhu et al, 2018, J Int Med Res CrossRef
3. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles
   Lucas Treps et al, 2017, Journal of Extracellular Vesicles CrossRef
4. A case report of targeted therapy with apatinib in a patient with recurrent high grade glioma
   Xiuping Ding et al, 2018, Medicine CrossRef
5. Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells
   Jinfang Xu et al, 2018, J Exp Clin Cancer Res CrossRef
6. Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression
   Ziyu Wu et al, 2017, Medicine CrossRef
7. Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
   Olivia G. Taylor et al, 2019, Front. Oncol. CrossRef
8. IDH1 mutation diminishes aggressive phenotype in glioma stem cells
   Qi Yao et al, 2017, Int J Oncol CrossRef
9. Therapeutic perspective of temozolomide resistance in glioblastoma treatment
   Qin Xia et al, 2021, Cancer Investigation CrossRef
10. Engineering antibody and protein therapeutics to cross the blood–brain barrier
    Peng Zhao et al, 2022 CrossRef
11. In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs
    Safura Pournajaf et al, 2024 CrossRef
12. Synthesis and Antitumour Evaluation of Tricyclic Indole‐2‐Carboxamides against Paediatric Brain Cancer Cells
    Alexander John Hamilton et al, 2024, ChemMedChem CrossRef